13F Filings/FARALLON CAPITAL MANAGEMENT LLC

FARALLON CAPITAL MANAGEMENT LLC

Hedge FundCIK0000909661LocationSAN FRANCISCO, CA 94111, United States

Long U.S. equity positions disclosed to the SEC on Form 13F-HR.

Latest filingQ2 2026Quarter ended30 Jun 2026Filed14 Aug 2026
Firm profile · Form ADV
SEC adviser registration

Farallon Europe provides investment advice to private investment funds and managed accounts, with discretionary authority over a significant portion of the Farallon Funds' assets. Its investment strategies are broad and flexible, including merger arbitrage, risk arbitrage, credit investing, real estate, direct investments, and long/short equity investing.Summarised from the firm’s Form ADV Part 2A brochure.

CRD
138713 · 801-65852
Portfolio Turnover
35%
Of book traded, QoQ
Positions
89
Long U.S. equities
Top 10 Concentration
62%
Of reported value
QoQ Change
$4.1B
Value change
Assets under management
Form ADV RAUM · client mix · 13F over time
Regulatory AUM
$4.1B
Form ADV, as of Jun 2024
● 100% discretionary ($4.1B)
By client type
Pooled investment vehicles: $4.1B (100.0%) · 67 clients
Pooled investment vehicles
$4.1B · 100%
13F AUM over time
$21.7B
Q2 ’26 · 13F AUM
▲ 316%
53 quarters
Reported Holdings
Q2 2026 · upgrade to Pro for past quarters
↗
★ Position spotlightRVMDREVOLUTION MEDICINES INC · 11.7% of bookThis highlighted stock and its 1Y chart are public
Loading position history…
Security⇅Shares⇅Market Value▼Est. Cost⇅Last Px⇅Est. Return⇅% Portfolio⇅Δ Shares⇅Action⇅
STATE STR SPDR S&P 500 ETF T
SPY
6.00MPut$4.5B—$770.19—20.7%NewNew
REVOLUTION MEDICINES INC
RVMD· Health Care
13.55MSH$2.5B~$187.28$210.02▲12.1%11.7%▼ 0.4%Reduced
ELECTRONIC ARTS INC
EA· Communication Services
7.92MSH$1.6B~$205.04$209.70▲2.3%7.5%NewNew
BRIDGEBIO PHARMA INC
BBIO· Health Care
10.74MSH$800.1M~$74.48$74.84▲0.5%3.7%▲ 14.7%Added
PROTAGONIST THERAPEUTICS INC
PTGX· Health Care
6.35MSH$778.2M~$122.58$145.72▲18.9%3.6%—Unchanged
EXELIXIS INC
EXEL· Health Care
13.47MSH$732.8M~$54.41$59.01▲8.5%3.4%▲ 2.7%Added
LIQUIDIA CORPORATION
LQDA· Health Care
8.37MSH$666.9M~$79.73$68.66▼13.9%3.1%▼ 3.4%Reduced
AMAZON COM INC
AMZN· Consumer Discretionary
2.63MSH$627.5M~$238.34$258.51▲8.5%2.9%▼ 37.6%Reduced
LANTHEUS HLDGS INC
LNTH· Health Care
5.58MSH$619.4M~$110.94$100.97▼9.0%2.9%—Unchanged
NATERA INC
NTRA· Health Care
2.22MSH$602.2M~$271.45$328.18▲20.9%2.8%▼ 30.8%Reduced
SPYSTATE STR SPDR S&P 500 ETF TNew
$4.5B· 20.7%· 6.00M Put· New· last $770.19
TR UNIT · OTR
RVMDREVOLUTION MEDICINES INCReduced
$2.5B· 11.7%· 13.55M SH· ▼ 0.4%· cost $187.28· last $210.02· ▲12.1%
Health Care · COM · OTR
EAELECTRONIC ARTS INCNew
$1.6B· 7.5%· 7.92M SH· New· cost $205.04· last $209.70· ▲2.3%
Communication Services · COM · OTR
BBIOBRIDGEBIO PHARMA INCAdded
$800.1M· 3.7%· 10.74M SH· ▲ 14.7%· cost $74.48· last $74.84· ▲0.5%
Health Care · COM · OTR
PTGXPROTAGONIST THERAPEUTICS INCUnchanged
$778.2M· 3.6%· 6.35M SH· —· cost $122.58· last $145.72· ▲18.9%
Health Care · COM · OTR
EXELEXELIXIS INCAdded
$732.8M· 3.4%· 13.47M SH· ▲ 2.7%· cost $54.41· last $59.01· ▲8.5%
Health Care · COM · OTR
LQDALIQUIDIA CORPORATIONReduced
$666.9M· 3.1%· 8.37M SH· ▼ 3.4%· cost $79.73· last $68.66· ▼13.9%
Health Care · COM NEW · OTR
AMZNAMAZON COM INCReduced
$627.5M· 2.9%· 2.63M SH· ▼ 37.6%· cost $238.34· last $258.51· ▲8.5%
Consumer Discretionary · COM · OTR
LNTHLANTHEUS HLDGS INCUnchanged
$619.4M· 2.9%· 5.58M SH· —· cost $110.94· last $100.97· ▼9.0%
Health Care · COM · OTR
NTRANATERA INCReduced
$602.2M· 2.8%· 2.22M SH· ▼ 30.8%· cost $271.45· last $328.18· ▲20.9%
Health Care · COM · OTR
1–10 of 89
1 / 9
Sector Breakdown
Q2 2026
Health Care51.4% · $11.1B
Unclassified27.5% · $6.0B
Communication Services8.4% · $1.8B
Information Technology5.7% · $1.2B
Consumer Discretionary4.0% · $869.1M
Financials1.7% · $378.0M
Industrials1.1% · $241.2M
Other0.1% · $28.1M
← All 13F filings